FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (IIB) or a pharmaceutically acceptable salt thereof. In formula (IIB), E is -CH2-; V is N; R12 is hydrogen; R15 denotes a difluoromethoxy group; R16 is hydrogen; R21 means piperidinyl, piperazinyl or morpholinyl, any of these groups may optionally contain 1, 2 or 3 substituents independently selected from C1-C6-alkylsulfonyl, oxo groups and carboxy groups; and R23 is hydrogen. Also the invention relates to a pharmaceutical composition, to the use of a compound, to a method for treating and/or preventing rheumatoid arthritis or Crohn's disease.
(IIB).
EFFECT: obtained new compounds of formula (IIB) with the properties of the modulator of TNFα activity.
6 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
TRIAZOLOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677698C1 |
IMIDAZOTHIAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2683940C1 |
IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2691629C1 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2684641C1 |
TRIAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677697C1 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696270C1 |
IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679609C1 |
CONDENSED BICYCLIC HETEROAROMATIC DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2685234C1 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2678305C1 |
Authors
Dates
2019-01-21—Published
2014-12-08—Filed